Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  CRDL | T.CRDL.W.A

Healthcare
Cardiol Therapeutics Inc. (Cardiol) is a Canada-based clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). The Company's lead product, CardiolRx, is a pharmaceutically produced oral cannabidiol formulation that is in a Phase II/III study in hospitalized patients testing positive... see more

Recent & Breaking News (TSX:CRDL)

Cardiol Therapeutics' Exclusive Manufacturing Partner Receives Three-Year Renewal and Amendment of its Cannabis Act License from Health Canada

Newsfile January 15, 2020

Cardiol Therapeutics Appoints Michael J. Willner, Esq. as Business Advisor

Newsfile December 18, 2019

Cardiol Therapeutics Appoints Former GW Pharmaceuticals Executive Colin Stott to Its Board of Directors

Newsfile December 3, 2019

Cardiol Therapeutics Comments on the Descheduling of Purisys Cannabinoid Ingredients by U.S. Drug Enforcement Agency

Newsfile November 25, 2019

Cardiol Therapeutics Announces Clinical Steering Committee for Phase 2 International Trial in Acute Myocarditis Using CardiolRx(TM) 100

Newsfile November 19, 2019

Cardiol Therapeutics Announces Completion of Manufacturing Scale-up for Commercialization of CardiolRx(TM)100

Newsfile October 1, 2019

Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing

PR Newswire September 16, 2019

/R E P E A T -- Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12th/

Canada NewsWire September 11, 2019

Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12th

PR Newswire September 6, 2019

Cardiol Therapeutics to Webcast Live at VirtualInvestorConferences.com on September 12th

Newsfile September 5, 2019

Cardiol Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference

Newsfile July 25, 2019

Grit Capital's Millennial Virtual Investor Conference Now Available for On-Demand Viewing

Canada NewsWire July 3, 2019

Grit Capital's Live-Stream Virtual Investor Conference June 26th

Canada NewsWire June 21, 2019

Cardiol Therapeutics Announces Plans for Orphan Drug Program in Acute Myocarditis with CardiolRx CBD Formulation

Newsfile June 20, 2019

Cardiol Therapeutics Reports Results of its AGM

Newsfile June 13, 2019

Cardiol Therapeutics to Webcast Annual General Meeting on June 12

Newsfile June 10, 2019

Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing

Canada NewsWire June 6, 2019

Cardiol Therapeutics to Webcast Live at VirtualInvestorConferences.com on June 4??

PR Newswire June 3, 2019

Cardiol Therapeutics' Pharmaceutical Partner Noramco Presents at U.S. FDA Public Hearing on CBD

Newsfile June 3, 2019

Live Investor Conference & Webinar: Cannabis Industry Companies Present June 4th

Canada NewsWire May 31, 2019